02 Oct Annual state biotech conference to focus on strategic partnerships
Madison, Wis. – Enabling member companies to build strategic partnerships and alliances will be the focus of the annual Wisconsin Biotechnology & Medical Device Association Conference, the WBMA announced.
The WBMA, which represents the state’s $8 billion bioscience industry, said global pharmaceutical and medical device companies, including Eli Lilly, Roche, Medtronic, and Johnson & Johnson, will explain their partnering strategies and processes to conference attendees.
The conference will be held on Wednesday, Oct. 22, from 7:30 a.m. to 6 p.m., at the Country Springs Hotel and Conference Center, Waukesha.
James L. Leonhart, executive director of the WBMA, said in a release that the 2008 conference theme is a direct result of feedback from member companies about the importance of strategic relationships to business growth. Sessions also will cover topics such virtual medical device product development.
“The 2008 WBMA conference is focused on providing Wisconsin’s biotechnology and medical device companies with the tools and information they need to build valuable, lasting relationships with key players in the global marketplace,” Leonhart said.
U.S. Rep. Paul Ryan, R-Wis., is scheduled to deliver the conference’s keynote address. Ryan played a role in crafting the economic rescue plan being considered in Congress.
The conference will conclude with a reception featuring Wisconsin Gov. Jim Doyle.
Registration information and material are available at www.wisbiomed.org.